Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation

被引:63
作者
Akasofu, S [1 ]
Kosasa, T [1 ]
Kimura, M [1 ]
Kubota, A [1 ]
机构
[1] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3002635, Japan
关键词
donepezil; acetylcholinesterase inhibitor; oxygen-glucose deprivation; LDH release; primary cultured cerebral cortical neuron; (rat);
D O I
10.1016/S0014-2999(03)01865-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Donepezil hydrochloride (donepezil: (+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-indan-1-one monohydrochloride) is a potent acetylcholinesterase inhibitor used for treatment of Alzheimer's disease. Although acetylcholinesterase inhibitors are used as a symptomatic treatment for Alzheimer's disease, it is not clear whether or not they are effective against progressive degeneration of neuronal cells. In this study, we investigated the neuroprotective effects of donepezil and other acetylcholinesterase inhibitors used for treatment of Alzheimer's disease, i.e., galantamine, rivastigmine, and tacrine. As a neurodegenerative model, we used rat cortical neurons exposed to oxygen-glucose deprivation. Lactate dehydrogenase (LDH) released into the culture medium was measured as a marker of neuronal cell damage. First, the effects of donepezil (10 muM) on three different treatment schedules (from 12 h before to 24 h after oxygen-glucose deprivation (pre-12 h), from 1 h before to 24 h after oxygen - glucose deprivation (pre- 1 h) and from 1 h after to 24 h after oxygen - glucose deprivation (post- 1 h)) were compared. The pre-12-h treatment most effectively inhibited LDH release. The protective effect of donepezil was confirmed morphologically. Next, the effects of donepezil and the other three acetylcholinesterase inhibitors were compared under the pre-12-h treatment condition. Donepezil (0.1, 1, and 10 muM) significantly decreased LDH release in a concentration-dependent manner. However, galantamine (1, 10, and 100 muM), tacrine (0.1, 1, and 10 muM), and rivastigmine (0.1, 1, and 10 muM) did not significantly decrease LDH release. The neuroprotective effect of donepezil was not antagonized by scopolamine or mecamylamine. These results demonstrate that donepezil has a protective effect against oxygen-glucose deprivation-induced injury to rat primary cultured cerebral cortical neurons. Besides, it is suggested that this effect of donepezil is independent of muscarinic cholinergic system and nicotinic cholinergic system. Thus, donepezil is expected to have a protective effect against progressive degeneration of brain neuronal cells in ischemic cerebrovascular disease and Alzheimer's disease. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 26 条
[1]   Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? [J].
Benzi, G ;
Moretti, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 346 (01) :1-13
[2]   Vascular risk factors for Alzheimer's disease: An epidemiologic perspective [J].
Breteler, MMB .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :153-160
[3]   Vascular involvement in cognitive decline and dementia - Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study [J].
Breteler, MMB .
VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 :457-465
[4]   Alzheimer disease as a vascular disorder - Nosological evidence [J].
de la Torre, JC .
STROKE, 2002, 33 (04) :1152-1162
[5]  
delaTorre JC, 1997, GERONTOLOGY, V43, P26
[6]  
Giacobini E, 2000, ANN NY ACAD SCI, V920, P321
[7]   Protection against ischemic injury in primary cultured astrocytes of mouse cerebral cortex by bis(7)-tacrine, a novel anti-Alzheimer's agent [J].
Han, YF ;
Wu, DC ;
Xiao, XA ;
Chen, PMY ;
Chung, W ;
Lee, NTK ;
Pang, YP ;
Carlier, PR .
NEUROSCIENCE LETTERS, 2000, 288 (02) :95-98
[8]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[9]   ROLE OF NERVE GROWTH-FACTOR IN OXIDANT-ANTIOXIDANT BALANCE AND NEURONAL INJURY .1. STIMULATION OF HYDROGEN-PEROXIDE RESISTANCE [J].
JACKSON, GR ;
APFFEL, L ;
WERRBACHPEREZ, K ;
PEREZPOLO, JR .
JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 25 (03) :360-368
[10]   Technical implications regarding surgical removal of a floating thrombus located in the ascending aorta or aortic arch [J].
Kalangos, A ;
Vala, D ;
Bednarkiewicz, M ;
Faidutti, B .
ANNALS OF VASCULAR SURGERY, 1999, 13 (01) :115-120